(1)
Buti, S.; Donini, M.; Lazzarelli, et al., S. A New Modified Schedule of Sunitinib for Metastatic Renal Cell Carcinoma: A Retrospective Analysis. Acta Biomed 2012, 83 (2), 88-94.